Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11.01 USD | -8.25% | -2.73% | +80.56% |
05-14 | Stephens Starts Inovio Pharmaceuticals With Overweight Rating, $20 Price Target | MT |
05-13 | Transcript : Inovio Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 13, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+80.56% | 311M | |
+41.04% | 50.93B | |
-0.40% | 42.12B | |
+49.62% | 42.05B | |
-7.20% | 29.18B | |
+12.83% | 26.02B | |
-21.45% | 18.9B | |
+7.04% | 13.21B | |
+24.52% | 12.17B | |
+30.49% | 12.16B |
- Stock Market
- Equities
- INO Stock
- News Inovio Pharmaceuticals, Inc.
- Transcript : Inovio Pharmaceuticals, Inc. Presents at RBC Capital Markets 2021 Global Healthcare Conference, May-18-2021 09